The Department of Transportation (DOT) made a final ruling on new drug testing panels that went into effect at the beginning of 2018. These revisions now include testing for expanded opiates – including hydrocodone, hydromorphone, oxymorphone, and oxycodone. Further details […]
Beginning January 1, 2018, the U.S. Department of Transportation (DOT) drug testing program will add testing for four semi-synthetic opioids (hydrocodone, oxycodone, hydromorphone, oxymorphone). The Federal Motor Carrier Safety Administration (FMCSA), along with the DOT, requires that persons subject to […]
FMCSA proposes changes to personal conveyance guidelines for commercial transportation companies.